As filed with the Securities and Exchange Commission on March 26, 2009
Registration Statement No. 333-83989
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Post-Effective Amendment No. 2 to
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Genentech, Inc.
(Exact name of Registrant as specified in its charter)
Delaware | 94-2347624 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) |
Genentech, Inc.
1 DNA Way
South San Francisco, California
94080
(Address of principal executive offices) (Zip Code)
1999 Stock Plan
1991 Employee Stock Plan
(Full title of the plans)
Sean A. Johnston
Genentech, Inc.
1 DNA Way
South San Francisco, California
94080
(650) 225-1000
(Name and address of agent for service) (Telephone number, including area code, of agent for service)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer x | Accelerated filer ¨ | Non-accelerated filer ¨ | Smaller reporting company ¨ | |||
(Do not check if a smaller reporting company) |
Explanatory Statement
On July 29, 1999, Genentech, Inc. (the Registrant) filed a Registration Statement on Form S-8 (File No. 333-83989) (the Registration Statement), which registered 7,500,000 shares of the Registrants common stock, par value $0.02 per share (the Common Stock) reserved for issuance under the 1999 Stock Plan. On November 2, 1999 the Registrant filed a Post-Effective Amendment No. 1 to the Registration Statement, which registered 7,500,000 shares of Common Stock reserved for issuance under the 1991 Employee Stock Plan. This Post-Effective Amendment No. 2 is being filed to deregister all authorized shares of Common Stock reserved for issuance under the 1999 Stock Plan and the 1991 Employee Stock Plan that have not yet been issued under the Registration Statement.
On March 12, 2009, the Registrant entered into an Agreement and Plan of Merger with Roche Holdings, Inc., a Delaware corporation (Parent) and Roche Investments USA Inc., a Delaware corporation and wholly-owned subsidiary of Parent (Roche Investments) (such agreement, the Merger Agreement), pursuant to which Roche Investments was merged with and into the Registrant and the Registrant became a wholly-owned subsidiary of Parent on March 26, 2009.
Accordingly, the Registrant hereby deregisters the shares of Common Stock that have not been and will not be issued under the 1999 Stock Plan. Upon effectiveness hereof, no shares of Common Stock remain registered under the Registration Statement for issuance under the 1999 Stock Plan.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment No. 2 to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of South San Francisco, in the State of California on March 26, 2009.
GENENTECH, INC. | ||
By: | /s/ Arthur D. Levinson | |
Arthur D. Levinson | ||
Chairman & Chief Executive Officer (Principal Executive Officer) |
Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.
Signature |
Title |
Date | ||
/s/ Arthur D. Levinson Arthur D. Levinson |
President & Chief Executive Officer (Principal Executive Officer) |
March 26, 2009 | ||
/s/ David A. Ebersman David A. Ebersman |
Executive Vice President & Chief Financial Officer (Principal Financial Officer) |
March 26, 2009 | ||
/s/ Robert E. Andreatta Robert E. Andreatta |
Vice President, Controller & Chief Accounting Officer (Principal Accounting Officer) |
March 26, 2009 | ||
/s/ Frank J. DAngelo Frank J. DAngelo |
Director | March 26, 2009 | ||
/s/ Frederick C. Kentz III Frederick C. Kentz III |
Director | March 26, 2009 | ||
/s/ David P. McDede David P. McDede |
Director | March 26, 2009 |
Registration Statement No. 333-83989